313c indicates that Despite the fact that not listed by name and CAS number, this chemical is reportable under a number of in the EPCRA part 313 chemical groups.Novel antidotes targeted at treating all routes of cyanide exposure, in addition to alternate methods of antidote administration such as oral, nebulized, sublingual, intramuscular, and subc